Personal CFO Solutions LLC Acquires 914 Shares of U.S. Physical Therapy, Inc. $USPH

Personal CFO Solutions LLC grew its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 15.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,703 shares of the company’s stock after purchasing an additional 914 shares during the quarter. Personal CFO Solutions LLC’s holdings in U.S. Physical Therapy were worth $524,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Nuveen LLC bought a new position in U.S. Physical Therapy during the first quarter valued at about $8,702,000. Bahl & Gaynor Inc. boosted its stake in U.S. Physical Therapy by 32.6% in the first quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company’s stock valued at $24,964,000 after acquiring an additional 84,878 shares during the last quarter. Copeland Capital Management LLC grew its position in shares of U.S. Physical Therapy by 8.9% during the 2nd quarter. Copeland Capital Management LLC now owns 888,735 shares of the company’s stock valued at $69,499,000 after acquiring an additional 72,463 shares during the period. Woodline Partners LP increased its stake in shares of U.S. Physical Therapy by 228.0% during the 1st quarter. Woodline Partners LP now owns 82,419 shares of the company’s stock worth $5,964,000 after purchasing an additional 57,293 shares during the last quarter. Finally, Jane Street Group LLC increased its stake in shares of U.S. Physical Therapy by 249.3% during the 1st quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock worth $3,568,000 after purchasing an additional 35,191 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on USPH shares. Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, October 8th. Barrington Research reaffirmed an “outperform” rating and set a $103.00 price target on shares of U.S. Physical Therapy in a research report on Friday, October 24th. Zacks Research upgraded U.S. Physical Therapy to a “hold” rating in a research note on Friday, August 8th. JPMorgan Chase & Co. started coverage on U.S. Physical Therapy in a report on Thursday, September 18th. They issued an “overweight” rating and a $110.00 price objective for the company. Finally, Wall Street Zen cut U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Sunday, September 21st. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $110.25.

Insider Activity

In related news, CFO Carey P. Hendrickson sold 698 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $86.11, for a total transaction of $60,104.78. Following the sale, the chief financial officer owned 27,808 shares of the company’s stock, valued at approximately $2,394,546.88. This represents a 2.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Eric Joseph Williams sold 1,000 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $85.25, for a total transaction of $85,250.00. Following the completion of the sale, the chief operating officer owned 25,331 shares in the company, valued at $2,159,467.75. This represents a 3.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 4,298 shares of company stock valued at $361,441 over the last ninety days. 2.00% of the stock is owned by insiders.

U.S. Physical Therapy Price Performance

U.S. Physical Therapy stock opened at $71.67 on Friday. The firm has a market capitalization of $1.09 billion, a P/E ratio of 31.30, a PEG ratio of 4.41 and a beta of 1.47. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $101.19. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. The business has a fifty day moving average price of $82.93 and a 200-day moving average price of $80.01.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 earnings per share (EPS) for the quarter. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The business had revenue of $140.66 million for the quarter. As a group, equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 12th. Stockholders of record on Monday, November 17th will be given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Monday, November 17th. U.S. Physical Therapy’s dividend payout ratio (DPR) is 75.63%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.